/PRNewswire/ W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, non-randomized, multicenter,.
/PRNewswire/ W. L. Gore & Associates, Inc. (Gore) announced that it is initiating the EMBRACE Registry to capture real-world data about the GORE® VIABAHN®.
/PRNewswire/ W. L. Gore & Associates (Gore) announced today that it is initiating the RELIEF Clinical Study – an investigational study to evaluate the.
/PRNewswire/ W. L. Gore & Associates (Gore) today announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently.